| Health / Medical Topics |
Pegfilgrastim Biosimilar LA-EP2006
A biosimilar of pegfilgrastim, a long-acting pegylated form of recombinant human granulocyte colony-stimulating factor (G-CSF) filgrastim, with hematopoietic activity. In a similar manner to G-CSF, pegfilgrastim biosimilar LA-EP2006 binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. Therefore, this agent may prevent the incidence and shorten the duration of chemotherapy-induced neutropenia. Conjugation of the cytokine with a branched polyethylene glycol molecule significantly increases this agent's therapeutic half-life compared to filgrastim. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to increase numbers of white blood cells in patients who are receiving chemotherapy. It is a type of colony-stimulating…
A pegylated form of a thermostable and protease resistant peptide targeting human vascular endothelial growth factor receptor-2 (VEGFR-2) with potential antiangiogenic…
A drug used to treat hepatitis C infections. It is also being studied in the treatment and prevention of cancer. It is…
A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the drug asparaginase that is linked to a…
The sodium salt form of pegaptanib, a 28-mer RNA aptamer covalently linked to two branched 20-kD polyethylene glycol (PEG) chains, with anti-angiogenic…
A 28-mer RNA aptamer covalently linked to two branched 20-kD polyethylene glycol (PEG) chains, with anti-angiogenic activity. Pegaptanib binds and blocks the…
